Syon Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$762K Buy
1,357
+287
+27% +$184K 0.04% 398
2025
Q4
$724K Buy
1,070
+54
+5% +$36.8K 0.04% 415
2025
Q3
$649K Buy
1,016
+103
+11% +$62.5K 0.03% 395
2025
Q2
$490K Sell
913
-63
-6% -$30.1K 0.03% 385
2025
Q1
$410K Buy
976
+167
+21% +$72.5K 0.03% 348
2024
Q4
$334K Buy
809
+57
+8% +$25K 0.03% 375
2024
Q3
$380K Sell
752
-160
-18% -$77.7K 0.03% 329
2024
Q2
$444K Buy
912
+170
+23% +$85.3K 0.04% 279
2024
Q1
$401K Sell
742
-690
-48% -$377K 0.04% 302
2023
Q4
$795K Buy
+1,432
New +$672K 0.03% 305

Other funds holding IDXX

Syon Capital's IDXX Position: Q1 2026 in Review

Syon Capital increased its Idexx Laboratories (IDXX) stake by 27% in Q1 2026, buying an estimated $184K and bringing the position to 1,357 shares worth $762K. The position accounts for 0.04% of the portfolio, ranked #398.

Syon Capital first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $795K in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Syon Capital held 1,357 shares of Idexx Laboratories worth $762K as of Q1 2026.
  • Syon Capital bought 287 Idexx Laboratories shares in Q1 2026, an estimated $184K.
  • Idexx Laboratories made up 0.04% of Syon Capital's portfolio in Q1 2026, its #398 holding.
  • Syon Capital first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Syon Capital's Idexx Laboratories position peaked at $795K in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.